Fulgent Genetics Inc. (FLGT) is a technology-based genetic testing company that provides comprehensive testing solutions for various diseases, including cancer, cardiovascular diseases, neurological disorders, and rare and undiagnosed diseases. The company's proprietary technology platform, called Picture Genetics, enables highly accurate and efficient genetic sequencing and analysis. Fulgent Genetics offers a wide range of testing services, including carrier screening, pharmacogenetics, and COVID-19 testing. The company's clients include healthcare providers, hospitals, and pharmaceutical companies. Fulgent Genetics is headquartered in Temple City, California, and as of September 2021, had a market capitalization of approximately $2.76 billion.
Fulgent Genetics Inc. (FLGT) is a technology-based genetic testing company that provides comprehensive testing solutions for various diseases, including cancer, cardiovascular diseases, neurological disorders, and rare and undiagnosed diseases. The company's proprietary technology platform, called Picture Genetics, enables highly accurate and efficient genetic sequencing and analysis. Fulgent Genetics offers a wide range of testing services, including carrier screening, pharmacogenetics, and COVID-19 testing. The company's clients include healthcare providers, hospitals, and pharmaceutical companies. Fulgent Genetics is headquartered in Temple City, California, and as of September 2021, had a market capitalization of approximately $2.76 billion.